Sustainability of Clinical Trials after the Historical Experience of COVID-19
Ardelean Mihai (),
Mihaicuta Stefan (),
Coroian Alexandra (),
Samfirescu Mircea () and
Dobre Andreas ()
Additional contact information
Ardelean Mihai: Politehnica University of Timișoara, Faculty of Engineering and Management, Timișoara, România
Mihaicuta Stefan: University of Medicine and Pharmacy „Victor Babes” Timișoara, Romania
Coroian Alexandra: Politehnica University of Timișoara, Faculty of Management in Production and Transportation, Timișoara, România
Samfirescu Mircea: Politehnica University of Timișoara, Faculty of Engineering and Management, Timișoara, România
Dobre Andreas: Politehnica University of Timișoara, Faculty of Engineering and Management, Timișoara, România
Proceedings of the International Conference on Business Excellence, 2025, vol. 19, issue 1, 5025-5034
Abstract:
Clinical trials are unknown to most people in Romania. Associated most of the time with innovative and advanced medicines for patients. Research of every new and innovative methods and drugs in medicine have a great impact economically, socially and medically. The Covid 19 pandemic, which has hit every part of the globe hard, has also meant for Romania and people to rediscover new words: RNA vaccine, study stages, vaccine efficiency, adverse effects. But all this was ideologically covered up with a lot of prejudices and preconceived ideas. Difficult to combat, every misconception found its place in the patient’s mind and succeeded, in addition to the resistance to getting vaccinated. Mass-media become a “specialist” in everything that modern medicine means and applied for the common good. The methodology of this research is based on the qualitative evaluation of the specialist literature and the analysis of existing data series in clinical trial management. The results show that clinical trials contribute to global sustainability and the bottlenecks developed by certain pandemic periods. Through this article we have tried to penetrate beyond prejudices and unfounded opinions most of the time.
Keywords: Sustainability; clinical trials; Covid-19; Management; investment; pandemic. (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://doi.org/10.2478/picbe-2025-0385 (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:vrs:poicbe:v:19:y:2025:i:1:p:5025-5034:n:1046
DOI: 10.2478/picbe-2025-0385
Access Statistics for this article
Proceedings of the International Conference on Business Excellence is currently edited by Alina Mihaela Dima
More articles in Proceedings of the International Conference on Business Excellence from Sciendo
Bibliographic data for series maintained by Peter Golla ().